Francesco Di Lorenzo
Overview
Explore the profile of Francesco Di Lorenzo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
1485
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Antonioni A, Raho E, Di Lorenzo F, Manzoli L, Flacco M, Koch G
J Neurol
. 2025 Mar;
272(3):252.
PMID: 40047958
Background: Alzheimer's disease (AD) is the leading cause of dementia worldwide, and cost-effective tools to detect amyloid pathology are urgently needed. Blood-based Tau phosphorylated at threonine 217 (pTau217) seems promising,...
2.
Assogna M, Di Lorenzo F, Bonni S, Borghi I, Cerulli Irelli E, Mencarelli L, et al.
Brain Commun
. 2025 Mar;
7(2):fcaf080.
PMID: 40046339
Frontotemporal dementia is a devastating neurodegenerative disorder for which no pharmacological treatments have been approved. Neuroinflammation plays a central role in driving the pathogenic mechanisms underlying frontotemporal dementia. In the...
3.
Salajkova Z, Barolo L, Baiocco P, Ruzicka B, Mura F, Di Lorenzo F, et al.
Sci Rep
. 2025 Mar;
15(1):7792.
PMID: 40044873
Fibrillated Tau proteins are believed to be a signature of Alzheimer's disease (AD) and may be potentially employed as a biosensor for AD early detection. Several studies revealed the presence...
4.
Cabreira V, Alty J, Antic S, Araujo R, Aybek S, Ball H, et al.
BMJ Neurol Open
. 2025 Mar;
7(1):e000918.
PMID: 40034653
Background: Functional cognitive disorder (FCD) poses a diagnostic challenge due to its resemblance to other neurocognitive disorders and limited biomarker accuracy. We aimed to develop a new diagnostic checklist to...
5.
Antonioni A, Di Lorenzo F
Neurol Int
. 2025 Feb;
17(2).
PMID: 39997662
Neurodegenerative dementia, a collective term for a range of disorders characterized by progressive cognitive and functional decline, is an urgent challenge in global healthcare [...].
6.
Antonioni A, Raho E, Manzoli L, Koch G, Flacco M, Di Lorenzo F
Alzheimers Dement (Amst)
. 2025 Jan;
17(1):e70068.
PMID: 39822285
Introduction: Blood-based biomarkers seem promising for the diagnosis of Alzheimer's disease (AD). Methods: We performed a systematic review and meta-analysis on the potential of blood phosphorylated Tau181 (p-tau181) to differentiate...
7.
Maida E, Abbadessa G, Di Lorenzo F, Palladino R, Moccia M, Iodice F, et al.
J Neurol
. 2024 Dec;
272(1):20.
PMID: 39666199
Background And Objectives: Editors of scientific journals play a key role in the health-related research process. Our study aims to characterize the demographics, work habits, decision-making processes, and ethical challenges...
8.
Perceived discrepancies in neurosonology training and certification across Europe: a RRFS/EAN survey
Tiu V, Duraes J, Di Lorenzo F, Vashchenko N, Gonzalez-Martinez A, Accorroni A, et al.
Front Neurol
. 2024 Nov;
15:1464946.
PMID: 39534267
Introduction: Neurosonology is a vital paraclinical investigation in modern neurology. However, access to education and certification in neurosonology for neurology residents and young specialists in Europe is challenging, and comprehensive...
9.
Serra L, Bonarota S, Di Domenico C, Caruso G, Giulietti G, Rizzuti M, et al.
J Alzheimers Dis
. 2024 Nov;
102(1):181-194.
PMID: 39497309
Background: Reserves' mechanisms explain inconsistencies between accumulation of neuropathological damage and clinical manifestations. Leisure activities are believed to promote reserves. Objective: This study evaluates whether cognitive, social, and physical leisure...
10.
Maiella M, Mencarelli L, Casula E, Borghi I, Assogna M, Di Lorenzo F, et al.
Clin Neurophysiol
. 2024 Sep;
167:177-188.
PMID: 39332078
Background: The neural activity of the Default Mode Network (DMN) is disrupted in patients with In Alzheimer's disease (AD). Objectives: We used a novel multimodal approach to track neural signal...